marketcap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
Medpace Holdings ROCE Ratio 2011-2025 | MEDP
Annual ROCE Ratio Medpace Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.13 | 60.26 | 72.13 | 20.84 | 20.73 | 15.91 | 14.21 | 8.56 | 6.48 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 72.13 | 6.48 | 30.36 |
Quarterly ROCE Ratio Medpace Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 153.46 | 117.9 | 58.37 | 42.0 | 60.04 | 65.33 | 71.6 | 62.9 | 85.14 | 89.36 | 90.58 | 54.12 | 60.1 | 43.84 | 27.56 | 16.51 | 22.27 | 22.05 | 20.8 | 13.91 | 18.88 | 17.25 | 18.36 | 17.52 | 17.67 | 18.11 | 17.21 | 17.06 | 14.97 | 13.82 | 13.09 | 12.85 | 11.93 | 10.58 | 9.65 | 8.59 | 6.27 | 5.94 | 3.63 | 1.53 | 1.74 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 153.46 | 1.53 | 34.99 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | $ 0.33 | -6.23 % | $ 30.6 M |  Germany |
 |
Fluidigm Corporation
FLDM
|
-18.87 | $ 3.75 | 1.08 % | $ 308 M |  USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | $ 2.99 | - | $ 399 M |  China |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | $ 21.99 | - | $ 562 M |  Britain |
 |
Genetron Holdings Limited
GTH
|
-15.41 | $ 4.03 | 0.12 % | $ 80.1 M | China |
 |
Chembio Diagnostics
CEMI
|
-132.81 | $ 0.46 | 0.22 % | $ 16.8 M | USA |
 |
Meridian Bioscience
VIVO
|
13.43 | $ 33.97 | - | $ 1.49 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | $ 0.48 | -20.0 % | $ 1.06 M | USA |
 |
Pacific Biosciences of California
PACB
|
-47.69 | $ 2.04 | -9.15 % | $ 517 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 28.02 | 3.05 % | $ 20 B |  Niderland |
 |
Quotient Limited
QTNT
|
232.42 | $ 0.32 | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quidel Corporation
QDEL
|
69.35 | $ 27.31 | -1.44 % | $ 1.15 B | USA |
 |
Bioventus
BVS
|
-47.08 | $ 7.55 | 15.09 % | $ 473 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | $ 165.21 | - | $ 10.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.8 | $ 565.36 | 0.07 % | $ 216 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | $ 119.99 | - | $ 1.31 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 1.01 | 2.98 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
-46.72 | $ 30.23 | -4.24 % | $ 1.75 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | $ 0.17 | -34.28 % | $ 263 K |  Israel |
 |
Biocept
BIOC
|
-360.98 | $ 0.43 | -13.05 % | $ 7.29 M | USA |
 |
Syneos Health
SYNH
|
11.41 | $ 42.98 | - | $ 4.46 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | $ 0.09 | - | $ 21.2 M | USA |
 |
DermTech
DMTK
|
-181.44 | $ 0.09 | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
58.25 | $ 0.29 | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
1.9 | $ 31.25 | 20.24 % | $ 868 M | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 13.47 | -1.97 % | $ 382 M | Israel |
 |
PerkinElmer
PKI
|
4.52 | $ 115.24 | -0.91 % | $ 14.7 B | USA |
 |
OpGen
OPGN
|
4.4 | $ 1.96 | -16.95 % | $ 1.54 M | USA |
 |
DexCom
DXCM
|
28.89 | $ 60.96 | 0.88 % | $ 23.5 B | USA |
 |
Organovo Holdings
ONVO
|
-120.24 | $ 2.12 | -2.3 % | $ 19.4 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 11.65 | -4.98 % | $ 125 M | China |
 |
Danaher Corporation
DHR
|
9.82 | $ 214.35 | 0.12 % | $ 157 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 6.05 | -3.9 % | $ 1.31 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.51 | -6.47 % | $ 5.77 M | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 22.72 | -1.69 % | $ 687 M | USA |
 |
Psychemedics Corporation
PMD
|
-43.78 | $ 2.67 | -1.84 % | $ 15.3 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | $ 0.77 | - | $ 7.1 B |  Australia |
 |
Renalytix AI plc
RNLX
|
376.98 | $ 0.21 | 5.66 % | $ 22.7 M | Britain |
 |
Myriad Genetics
MYGN
|
-17.62 | $ 6.56 | -19.8 % | $ 594 M | USA |
 |
IQVIA Holdings
IQV
|
36.29 | $ 211.79 | -1.0 % | $ 38.4 B | USA |
 |
CareDx, Inc
CDNA
|
-77.82 | $ 14.33 | -3.01 % | $ 770 M | USA |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 16.72 | -3.8 % | $ 99.4 M | Israel |
|
Biodesix
BDSX
|
-41.6 | $ 7.52 | 18.53 % | $ 975 M | USA |
 |
T2 Biosystems
TTOO
|
177.14 | $ 0.12 | -39.35 % | $ 313 K | USA |
 |
OPKO Health
OPK
|
-7.58 | $ 1.4 | -0.36 % | $ 972 M | USA |
 |
Guardant Health
GH
|
317.65 | $ 98.81 | -0.12 % | $ 12.1 B | USA |
 |
Agilent Technologies
A
|
25.0 | $ 146.82 | 1.47 % | $ 44.6 B | USA |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 0.39 | -3.37 % | $ 11.4 M | USA |
 |
Lantheus Holdings
LNTH
|
42.0 | $ 57.99 | 2.06 % | $ 4.01 B | USA |